当前位置: X-MOL 学术J. Endocrinol. Investig. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Micronutrients in support to the one carbon cycle for the modulation of blood fasting homocysteine in PCOS women.
Journal of Endocrinological Investigation ( IF 5.4 ) Pub Date : 2019-12-16 , DOI: 10.1007/s40618-019-01163-x
N Schiuma 1 , A Costantino 1 , T Bartolotti 1 , M Dattilo 2 , V Bini 3 , M C Aglietti 3 , M Renga 3 , A Favilli 4 , A Falorni 3 , S Gerli 4
Affiliation  

PURPOSE Fasting blood homocysteine is increased in PCOS women and is involved in several of its co-morbidities including cardiovascular disease and infertility. Corrective interventions based on the administration of supra-physiologic doses of folic acid work to a low extent. We aimed to test an alternative approach. METHODS This was a prospective, randomized, parallel group, open label, controlled versus no treatment clinical study. PCOS women aged > 18, free from systemic diseases and from pharmacological treatments were randomized with a 2:1 ratio for treatment with activated micronutrients in support to the carbon cycle (Impryl, Parthenogen, Switzerland-n = 22) or no treatment (n = 10) and followed-up for 3 months. Fasting blood homocysteine, AMH, testosterone, SHBGs, and the resulting FTI were tested before and at the end of the follow-up. RESULTS The mean baseline fasting blood homocysteine was above the normal limit of 12 μMol/L and inversely correlated with SHBG. AMH was also increased, whereas testosterone, SHBG, and FTI were within the normal limit. The treatment achieved a significant reduction of homocysteine, that did not change in the control group, independently of the starting value. The treatment also caused an increase of AMH and a decrease of SHBGs only in the subgroup with a normal homocysteine at baseline. CONCLUSIONS In PCOS ladies, blood homocysteine is increased and inversely correlated with the SHBGs. Physiologic amounts of activated micronutrients in support to the carbon cycle achieve a reduction virtually in all exposed patients. Whether this is of clinical benefit remains to be established.

中文翻译:

微量营养素支持PCOS妇女中一个禁食碳半胱氨酸的碳循环调节。

目的空腹血液中的高半胱氨酸在PCOS妇女中增加,并且参与多种并发症,包括心血管疾病和不育症。基于超生理剂量叶酸管理的矫正干预作用很小。我们旨在测试一种替代方法。方法这是一项前瞻性,随机,平行组,开放标签,对照或无治疗的临床研究。将年龄≥18岁,无系统性疾病和药物治疗的PCOS妇女以2:1的比例随机分配,以支持碳循环的活化微量营养素(Impryl,Parthenogen,瑞士-n = 22)或不进行治疗(n = 10),并随访3个月。空腹血同型半胱氨酸,AMH,睾丸激素,SHBGs和所得的FTI在随访之前和结束时进行了测试。结果平均基线空腹血同型半胱氨酸高于正常水平12μMol/ L,与SHBG呈负相关。AMH也升高,而睾丸激素,SHBG和FTI均在正常范围内。该处理实现了高半胱氨酸的显着降低,而对照组中的高半胱氨酸没有改变,与起始值无关。该治疗还仅在基线时具有同型半胱氨酸正常的亚组中引起AMH升高和SHBG降低。结论在PCOS女士中,血液中的高半胱氨酸水平升高,与SHBG呈负相关。在所有暴露的患者中,支持碳循环的活化微量营养素的生理量实际上都减少了。这是否具有临床益处还有待确定。
更新日期:2019-12-16
down
wechat
bug